Literature DB >> 12633788

Trabecular minimodeling in human iliac bone.

S Kobayashi1, H E Takahashi, A Ito, N Saito, M Nawata, H Horiuchi, H Ohta, A Ito, R Iorio, N Yamamoto, K Takaoka.   

Abstract

In adult human beings, remodeling creates nearly all of new bone tissue. However, Frost hypothesized that modeling can go on in trabeculae throughout life. As this hypothesis has not been verified, we looked for histologic evidence of trabecular modeling (minimodeling) during bone histomorphometry of transiliac bone biopsy specimens obtained from 34 patients (age range, 38-81 years; mean age, 58.4 years; female, 31/34) at the time of total hip arthroplasty. Before the bone biopsy study, we performed quantitative bone scintigraphy of bilateral hip joints and bilateral iliac crests in 10 other patients with unilateral hip disease and confirmed that the bone biopsy site was not affected by ipsilateral hip joint disease. Patients who had metabolic bone diseases or who had taken medications known to affect bone metabolism were excluded from the study. During modeling where bone formation and bone resorption are not coupled, bone formation can occur on quiescent bone surfaces without preceding bone resorption and create smooth cement lines. Therefore, the combination of fluorochrome labeling and a smooth cement line without interruption of surrounding collagen fibers was regarded as evidence of minimodeling. Histologic evidence of minimodeling was detected in 21 of the entire 34 specimens (62%) and 17 of 27 specimens obtained from postmenopausal patients (63%). Bone volume of minimodeling sites was less than 1% of the trabecular bone volume, and these sites accounted for less than 2% of the entire bone surface on average. However, osteoid volume of minimodeling sites comprised approximately one-tenth of the entire osteoid volume, and their labeled surface constituted one-fourth to half of the entire labeled surface on average. Therefore, when performing bone histomorphometry of adult cancellous bone, minimodeling should be taken into account when dealing with parameters related to osteoid volume and mineralization. A comparison of specimens with and without minimodeling demonstrated that the presence of minimodeling was correlated with smaller physique of patients, accelerated mineralization (as indicated by the higher mean MS/BS and MAR values and the shorter mean Omt), and higher metabolic turn-over of bone (as indicated by the higher mean BFR/BV value). Although the findings still need to be verified in a larger number of normal subjects without hip joint disease, they support Frost's hypothesis that minimodeling can continue throughout human life.

Entities:  

Mesh:

Year:  2003        PMID: 12633788     DOI: 10.1016/s8756-3282(02)00947-x

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  18 in total

Review 1.  Normal bone anatomy and physiology.

Authors:  Bart Clarke
Journal:  Clin J Am Soc Nephrol       Date:  2008-11       Impact factor: 8.237

2.  Alendronate does not prevent long bone fragility in an inactive rat model.

Authors:  K Naruse; K Uchida; M Suto; K Miyagawa; A Kawata; K Urabe; M Takaso; M Itoman; Y Mikuni-Takagaki
Journal:  J Bone Miner Metab       Date:  2015-10-16       Impact factor: 2.626

Review 3.  Acute and Stress-related Injuries of Bone and Cartilage: Pertinent Anatomy, Basic Biomechanics, and Imaging Perspective.

Authors:  Mini N Pathria; Christine B Chung; Donald L Resnick
Journal:  Radiology       Date:  2016-07       Impact factor: 11.105

Review 4.  Mechanical, hormonal and metabolic influences on blood vessels, blood flow and bone.

Authors:  Rhonda D Prisby
Journal:  J Endocrinol       Date:  2017-08-16       Impact factor: 4.286

5.  Intermittent Parathyroid Hormone After Prolonged Alendronate Treatment Induces Substantial New Bone Formation and Increases Bone Tissue Heterogeneity in Ovariectomized Rats.

Authors:  Allison R Altman-Singles; Yonghoon Jeong; Wei-Ju Tseng; Chantal Mj de Bakker; Hongbo Zhao; Carina Lott; Juhanna Robberts; Ling Qin; Lin Han; Do-Gyoon Kim; X Sherry Liu
Journal:  J Bone Miner Res       Date:  2017-06-13       Impact factor: 6.741

Review 6.  Bone modeling and remodeling: potential as therapeutic targets for the treatment of osteoporosis.

Authors:  Bente Langdahl; Serge Ferrari; David W Dempster
Journal:  Ther Adv Musculoskelet Dis       Date:  2016-10-05       Impact factor: 5.346

7.  Ontogenetic changes in the internal and external morphology of the ilium in modern humans.

Authors:  Richard Abel; Gabriele A Macho
Journal:  J Anat       Date:  2011-03       Impact factor: 2.610

8.  Bone histomorphometry in a long-term hemodialysis patient with hypoparathyroidism and sarcoidosis.

Authors:  K Sumida; Y Ubara; J Hoshino; N Hayami; T Suwabe; R Hiramatsu; E Hasegawa; M Yamanouchi; N Sawa; T Fujii; K Takaichi
Journal:  Osteoporos Int       Date:  2014-12-13       Impact factor: 4.507

9.  Alfacalcidol treatment increases bone mass from anticatabolic and anabolic effects on cancellous and cortical bone in intact female rats.

Authors:  Xiao Qing Liu; Hai Yan Chen; Xiao Yan Tian; Rebecca B Setterberg; Mei Li; Webster S Jee
Journal:  J Bone Miner Metab       Date:  2008-08-30       Impact factor: 2.626

10.  Activation, development, and attenuation of modeling- and remodeling-based bone formation in adult rats.

Authors:  Wenzheng Wang; Wei-Ju Tseng; Hongbo Zhao; Tala Azar; Shaopeng Pei; Xi Jiang; Nathaniel Dyment; X Sherry Liu
Journal:  Biomaterials       Date:  2021-07-09       Impact factor: 15.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.